PAION AG is a publicly listed specialty pharmaceutical company developing and aiming to commercialize innovative drugs for out-patient and hospital-based sedation, anesthesia and critical care services.

 

Learn more About PAION

news

08/12/2020

Consolidated Financial Interim Report for the First Half Year 2020

Consolidated Financial Interim Report for the First Half-Year...

Read more
08/12/2020

PAION AG REPORTS FINANCIAL RESULTS FOR THE FIRST HALF-YEAR 2020

DGAP-News: PAION AG / Key word(s): Half Year Results12.08.2020 /...

Read more
08/11/2020

PAION ANNOUNCES PROGRESS WITH REMIMAZOLAM BY ITS PARTNER YICHANG HUMANWELL IN...

DGAP-News: PAION AG / Key word(s): Miscellaneous11.08.2020 /...

Read more

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.